Taken together, results of molecular modeling and western blot analysis strengthen each other, and support the impact of RUT in modulating Nrf2 pathway, and the possibility that RUT could represent a novel approach in MS treatment. The gene discussed is NFE2L2; the disease is myeloid sarcoma.